YOUR BUSINESS AUTHORITY
Springfield, MO
Drugmaker Regeneron Pharmaceuticals is set to buy genetic testing firm 23andMe through bankruptcy proceedings.
The deal is valued at $256 million.
23andMe has collected genetic data from some 15 million customers.
Read more from Reuters.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year